In vitro antimicrobial, antioxidant and cytotoxic properties of Streptomyces lavendulae strain SCA5

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Kumar, Pachaiyappan Saravana ^a   Al Dhabi, Naif Abdullah ^b   Duraipandiyan, Veeramuthu ^b   Balachandran, Chandrasekar ^a   Kumar, Panthagani Praveen ^a   Ignacimuthu, Savarimuthu ^a,b  

^a LOYOLA COLLEGE   (India)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antimicrobial; Antioxidant; Cytotoxicity; SCA5

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACETIC ACID ETHYL ESTER; ACTINOMYCIN C2; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTIOXIDANT; BACTERIAL EXTRACT; HYDROXYL RADICAL; NITRIC OXIDE; PHENOL DERIVATIVE; STREPTOMYCES LAVENDULAE EXTRACT; SUPEROXIDE; UNCLASSIFIED DRUG; BIOLOGICAL FACTOR;

ADENOCARCINOMA CELL LINE; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG ISOLATION; IC50; IN VITRO STUDY; LIPID PEROXIDATION; LUNG ADENOCARCINOMA; MALE; MASS FRAGMENTOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAT; ADENOCARCINOMA; ANIMAL; DRUG EFFECTS; HUMAN; LIVER; LUNG NEOPLASMS; METABOLISM; STREPTOMYCES; TUMOR CELL LINE; WISTAR RAT;

ADENOCARCINOMA; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIOXIDANTS; BIOLOGICAL FACTORS; CELL LINE, TUMOR; HUMANS; IN VITRO TECHNIQUES; LIPID PEROXIDATION; LIVER; LUNG NEOPLASMS; MALE; RATS; RATS, WISTAR; STREPTOMYCES;

EID: 84988642954     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-014-0291-6     Document Type: Article

References (50)

1. Wise R: The world wide threat of antimicrobial resistance. Curr Sci 2008, 95:181-187.
2. Hoake JB, Pastorino JG: Ethanol, oxidative stress and cytokine-induced liver cell injury. Alcohol 2002, 27:63-68.
3. Barlow SM: Toxicological aspects of antioxidants uses as food additives. In Food Antioxidants. Edited by Hudson BJF. London: Elsevier; 1990:253-307.
4. Grabley S, Hiericke R: The Impact of Natural Products on Drug Discovery. In Drugs Discovery from Nature. Edited by Grabley S, Thiericke R. Berlin: Springer-Verlag; 1999:1-37.
5. Pimentel-Elardo SM, Kozytska S, Bugni TS, Ireland CM, Moll H, Hentschel U: Anti-parasitic compounds from Streptomyces spp. strains isolated from Mediterranean sponges. Mar Drugs 2010, 8:373-380.
6. Demain AL, Sanchez S: Microbial drug discovery: 80 years of progress. J Antibiot 2009, 62:5-16.
7. Bush K, Macielag M: New approaches in the treatment of bacterial infections. Curr Opin Chem Biol 2000, 4:433-439.
8. Ikeda H, Ishikawa J, Hanamoto A, Shinose M, Kikuchi H, Shiba T, Sakaki Y, Hattori M, Omura S: Complete genome sequence and comparative analysis of the industrial microorganism Stretomyces avermitilis. Nat Biotechnol 2003, 21:526-531.
9. Arumugam M, Mitra A, Jaisankar P, Dasgupta S, Sen T, Ratan R, Kumar Mukhopadhyay U, Mukherjee J: Isolation of an unusual metabolite 2-allyloxyphenol from a marine actinobacterium, its biological activities and applications. Appl Microbiol Biotechnol 2010, 86:109-117.
10. Shin HJ, Kim TS, Lee HS, Park JY, Choi IK, Kwon HJ: Streptopyrrolidine, an angiogenesis inhibitor from a marine derived Streptomyces spp. KORDI-3973. Phytochem 2008, 69:2363-2366.
11. Ellaiah P, Kalyan D, Rao VS, Rao BV: Isolation and characterization of bioactive actinomycetes from marine sediments. Hindustan Antibiot Bull 1996, 38:48-52.
12. Oskay M: Antifungal and antibacterial compounds from Streptomyces strains. Afr J Biotechnol 2009, 8(13):3007-3017.
13. Anand PT, Edward JKP: Antimicrobial activity in the ⋯ Nathan, P., E.J. Law, D.F. Murphy and B.G. MacMillan, 1978. A laboratory for the selection of topical antimicrobial agents. Burns 2002, 4:177-178.
14. Shirling JL, Gottlieb D: Methods for characterization of Streptomyces species. Int J Syst Evol Microbiol 1966, 16:313-340.
15. Yan XC: Isolation and Identification of Actinomycete. Beijing: Science; 1992:45-68.
16. Balachandran C, Duraipandiyan V, Balakrishna K, Ignacimuthu S: Petroleum and polycyclic aromatic hydrocarbons (PAHs) degradation and naphthalene metabolism in Streptomyces sp. (ERI-CPDA-1) isolated from oil contaminated soil. Bioresour Technol 2012, 112:83-90.
17. Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
18. Bauer AW, Kirby WMM, Sherris JC, Truck M: Antibiotic suspectibility testing by a standardized single disk method. A M J Clin Pathol 1966, 45:493-496. PMID, 535257071.
19. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Fothergill A, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL, Verweij PE: Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study. J Clin Microbiol 2005, 43(10):5243-5246.
20. Sunil C, Agastian P, Kumarappan C, Ignacimuthu S: In vitro antioxidant, antidiabetic and antilipidemic activities of Symplocos cochinchinensis (Lour.) S. Moore bark. Food Chem Toxicol 2012, 50:1547-1553.
21. Parejo I, Codina C, Petrakis C, Kefalas P: Evaluation of scavenging activity assessed by Co (II)/EDTAinduced luminol chemiluminescence and DPPH free radical assay. J Pharmacol Toxicol Methods 2000, 44:507-512.
22. Garratt DC: The Quantitative Analysis of Drugs, vol 3. Tokyo: Chapman and Hall; 1964:456-458.
23. Chu Y, Chang C, Hsu H: Flavonoid content of several vegetables and their antioxidant activity. J Sci Food Ag 2000, 80:561-566.
24. Yen GC, Hsieh CL: Antioxidant activity of extracts from Du-zhong (Eucommia urmoides) towards various peroxidation models in vitro. J Agric Food Chem 1998, 46:3952-3957.
25. Singleton VL, Rossi JA: Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagent. Am J Enol Vitic 1965, 16:144-158.
26. Oktay M, Gülcin, I, Küfrevioǧlu OI: Determination of in vitro antioxidant activity of fennel (Foeniculum vulgare) seed extracts. Lebebsm Wiss Technol 2003, 36:263-271.
27. Hsu H, Huang K, Lu K, Chiou S, Yen J, Chang C, Houng J: Typhonium blumei extract inhibits proliferation of human lung adenocarcinoma A549 cells via induction of cell cycle arrest and apoptosis. J Ethnopharmacol 2011, 135:492-500.
28. Balachandran C, Duraipandiyan V, Balakrishna K, Lakshmi Sundaram R, Vijayakumar A, Ignacimuthu S, Al-Dhabi NA: Synthesis and medicinal properties of plant-derived vilangin. Environ Chem Let 2013, doi:10.1007/ s10311-013-0408-4.
29. Saravana Kumar P, Duraipandiyan V, Ignacimuthu S: Isolation, screening and partial purification of antimicrobial antibiotics from soil Streptomyces sp. SCA 7. Kaohsiung J Med Sci 2014, 30:435-446.
30. Miyadoh S: Research on antibiotic screening in Japan over the last decade: a producing microorganisms approach. Actinomycetologica 1993, 9:100-106.
31. Mukherjee G, Sen S: Characterization and idntfication of chitinase producing streptomyces venezulaae P10. Indian J Exp Biol 2004, 42:541-544.
32. Grube M, Cardinale M, de Castro JV Jr, Müller H, Berg G: Species-species structural and functional diversity of bacterial communities in lichens symbioses. ISME J 2009, 3:1105-1115.
33. Hacène H, Daoudi-Hamdad F, Bhatnagar T, Baratti JC, Lefebvre G: A new aminoglycosidase anti Pseudomonas antibiotic produced by a new strain of Spirillosora. Microbiol 2000, 102:69.
34. Saravana Kumar P, Preetam Raj John P, Duraipandiyan V, Ignacimuthu S: Antibacterial activity of some actinomycetes from Tamil Nadu, India. Asian Pac J Trop Biomed 2012, 2(12):974-981.
35. Vijayakumar R, Panneer Selvam K, Muthukumar C, Thajuddin N, Panneerselvam A, Saravanamuthu R: Antimicrobial potentiality of a halophilic strain of Streptomyces sp. VPTSA18 isolated from saltpan environment of Vedaranyam, India. Ann Microbiol 2012, 62:1039-1047.
36. Braca A, De Tommasi N, Di Bari L, Pizza C, Politi M, Morelli I: Antioxidant principles from Bauhinia terapotensis. J Nat Prod 2001, 64:892-895.
37. Aruoma OI: Free radicals, oxidative stress, and antioxidants in human health and disease. J Am Oil Chem Soc 1998, 75:199-212.
38. Halliwell B, Gutteridge JMC: Oxygen toxicology, oxygen radicals, transition metals and disease. Biochem J 1984, 219:1-4.
39. Parejo I, Viladomat F, Bastida J, Rosas-Romero A, Flerlage N, Burillo J, Codina C: Comparison between the radical scavenging activity and antioxidant activity of six distilled and nondistilled Mediterranean herbs and aromatic plants. J Agric Food Chem 2002, 50:6882-6890.
40. Meir S, Kanner J, Akiri B, Hadas SP: Determination and involvement of aqueous reducing compounds in oxidative defense systems of various senescing leaves. J Agric Food Chem 1995, 43:1813-1817.
41. Maskey RP, Li FCS, Qin HH, Fiebig Laatsch H: Chandrananimycins A-C: production of novel anticancer antibiotics from a marine Actinomadura spp. isolate M048 by variation ofmedium composition and growth conditions. J Antibiot 2003, 56:622-629.
42. Joseph Selvin S, Shanmughapriya R, Gandhimathi G, Seghal Kiran T, Rajeetha Ravji K, Natarajaseenivasan T, Hema A: Optimization and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsis dassonvillei MAD08. Appl Microbiol Biotechnol 2009, 83:435-445.
43. Smolinske SC: CRC Handbook of Food, Drug, and Cosmetic Excipients. Detroit, MI, USA: Poison Control Center; 1992:247-248.
44. Caixia C, Fuhang S, Qian W, Wael M, Abdel-Mageed, Hui G, Chengzhang F, Weiyuan H, Huanqin D, Xueting L, Na Y, Feng X, Ke Y, Ruxian C, Lixin Z: A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity. Appl Microbiol Biotechnol 2012, 95:919-927.
45. Arda-Pirincci P, Bolkent S: The role of glucagon-like peptide-2 on apoptosis, cell proliferation, and oxidant-antioxidant system at a mouse model of intestinal injury induced by tumor necrosis factor-alpha/ actinomycin D. Mol Cell Biochem 2011, 350:13-27.
46. Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, Kose M: Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Int J Gynecol Cancer 2006, 16(3):1432-1438.
47. Abd El-Aal H, Habib E, Mishrif M: Wilms' tumor: the experience of the pediatric unit of Kasr El-Aini center of radiation oncology and nuclear medicine (NEMROCK). J Egypt Natl Canc Inst 2005, 17(4):308-311.
48. Khatua S, Nair C, Ghosh K: Immune-mediated thrombocytopenia following dactinomycin therapy in a child with alveolar rhabdomyosarcoma: the unresolved issues. J Pediatr Hematol Oncol 2004, 26(11):777-779.
49. Jaffe N, Paed D, Traggis D, Salian S, Cassady JR: Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy. Cancer 1976, 38(5):1925-1930.
50. Uberti EMH, Fajardo MDC, Ferreira SVVR, Pereira MCV, Seger RC, Moreira MALR, Torres MD, De Nápoli G, Schmid H: Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy. Gynecol Oncol 2009, 115(3):476-481.